Wall Street Financial Group’s Labcorp LH Stock Holding History

Wall Street Financial Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3	Closed	-$800	–	390
2026 Q1	$800	Buy	+3	New	+$812	﹤0.01%	610

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wall Street Financial Group's LH Position: Q2 2026 in Review

Wall Street Financial Group sold out of Labcorp (LH) in Q2 2026, closing a stake of 3 shares — an estimated $800 sold.

Wall Street Financial Group first reported a position in LH in Q1 2026 and held it in 1 quarter. The position peaked at $800 in Q1 2026. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Wall Street Financial Group reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
Wall Street Financial Group sold 3 Labcorp shares in Q2 2026, an estimated $800.
Wall Street Financial Group first reported a position in Labcorp in Q1 2026 and held it in 1 quarter.
Wall Street Financial Group's Labcorp position peaked at $800 in Q1 2026.
1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.